Serina Therapeutics, Inc. Amortization of Intangible Assets
Serina Therapeutics, Inc. (SER) reported Amortization of Intangible Assets of $100.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-25
- Serina Therapeutics, Inc. amortization of intangible assets for the quarter ending 2024-06-30 was $33.00K, a 3.13% increase year-over-year.
- Serina Therapeutics, Inc. amortization of intangible assets for the quarter ending 2024-03-31 was $2.00K, a 93.94% decline year-over-year.
- Serina Therapeutics, Inc. amortization of intangible assets for the quarter ending 2023-12-31 was $33.00K, a 0.00% change year-over-year.
- Serina Therapeutics, Inc. amortization of intangible assets for the quarter ending 2023-09-30 was $33.00K, a 0.00% change year-over-year.
- Serina Therapeutics, Inc. amortization of intangible assets for fiscal 2024 was $100.00K, a 23.66% decline from fiscal 2023.
- Serina Therapeutics, Inc. amortization of intangible assets for fiscal 2023 was $131.00K, a 0.76% decline from fiscal 2022.
- Serina Therapeutics, Inc. amortization of intangible assets for fiscal 2022 was $132.00K, a 0.76% increase from fiscal 2021.
- Serina Therapeutics, Inc. amortization of intangible assets for fiscal 2021 was $131.00K, a 0.76% decline from fiscal 2020.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $100.00K 10-K · filed 2026-03-25 | |||||||
| 2024-06-30 | $33.00K 10-Q · filed 2024-08-09 | $35.00K 10-Q · filed 2024-08-09 | $68.00K derived: sum of 3 quarters · filed 2024-08-09 | $101.00K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2024-03-31 | $2.00K 10-Q · filed 2024-05-14 | $35.00K derived: sum of 2 quarters · filed 2024-05-14 | $68.00K derived: sum of 3 quarters · filed 2024-05-14 | $100.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2023-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $66.00K derived: sum of 2 quarters · filed 2024-03-22 | $98.00K derived: sum of 3 quarters · filed 2024-03-22 | $131.00K 10-K · filed 2024-03-22 | ||||
| 2023-09-30 | $33.00K 10-Q · filed 2023-11-14 | $65.00K derived: sum of 2 quarters · filed 2023-11-14 | $98.00K 10-Q · filed 2023-11-14 | $131.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-06-30 | $32.00K 10-Q · filed 2023-08-14 | $65.00K 10-Q · filed 2023-08-14 | $98.00K derived: sum of 3 quarters · filed 2024-03-22 | $131.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-03-31 | $33.00K 10-Q · filed 2023-05-12 | $66.00K derived: sum of 2 quarters · filed 2024-03-22 | $99.00K derived: sum of 3 quarters · filed 2024-03-22 | $132.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2022-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $66.00K derived: sum of 2 quarters · filed 2024-03-22 | $99.00K derived: sum of 3 quarters · filed 2024-03-22 | $132.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $33.00K 10-Q · filed 2023-11-14 | $66.00K derived: sum of 2 quarters · filed 2023-11-14 | $99.00K 10-Q · filed 2023-11-14 | $132.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $33.00K 10-Q · filed 2023-08-14 | $66.00K 10-Q · filed 2023-08-14 | $99.00K derived: sum of 3 quarters · filed 2023-08-14 | $131.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $33.00K 10-Q · filed 2023-05-12 | $66.00K derived: sum of 2 quarters · filed 2023-05-12 | $98.00K derived: sum of 3 quarters · filed 2023-05-12 | $131.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $65.00K derived: sum of 2 quarters · filed 2023-03-31 | $98.00K derived: sum of 3 quarters · filed 2023-03-31 | $131.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $65.00K derived: sum of 2 quarters · filed 2022-11-10 | $98.00K 10-Q · filed 2022-11-10 | $132.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $33.00K 10-Q · filed 2022-08-12 | $66.00K 10-Q · filed 2022-08-12 | $100.00K derived: sum of 3 quarters · filed 2022-08-12 | $133.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-13 | $67.00K derived: sum of 2 quarters · filed 2022-05-13 | $100.00K derived: sum of 3 quarters · filed 2022-05-13 | $133.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $67.00K derived: sum of 2 quarters · filed 2022-03-29 | $100.00K derived: sum of 3 quarters · filed 2022-03-29 | $132.00K 10-K · filed 2022-03-29 | $559.00K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $33.00K 10-Q · filed 2021-11-12 | $140.00K 10-Q · filed 2020-11-16 | $66.00K derived: sum of 2 quarters · filed 2021-11-12 | $98.00K 10-Q · filed 2021-11-12 | $419.00K 10-Q · filed 2020-11-16 | $238.00K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $33.00K 10-Q · filed 2021-08-13 | $139.00K 10-Q · filed 2020-08-14 | $65.00K 10-Q · filed 2021-08-13 | $279.00K 10-Q · filed 2020-08-14 | $205.00K derived: sum of 3 quarters · filed 2021-08-13 | $345.00K derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $33.00K 10-Q · filed 2021-05-17 | $140.00K 10-Q · filed 2020-05-14 | $172.00K derived: sum of 2 quarters · filed 2021-05-17 | $312.00K derived: sum of 3 quarters · filed 2021-05-17 | $452.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $279.00K derived: sum of 2 quarters · filed 2021-03-31 | $419.00K derived: sum of 3 quarters · filed 2021-03-31 | $558.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $140.00K 10-Q · filed 2020-11-16 | $280.00K derived: sum of 2 quarters · filed 2020-11-16 | $419.00K 10-Q · filed 2020-11-16 | $559.00K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $140.00K 10-Q · filed 2020-08-14 | $279.00K 10-Q · filed 2020-08-14 | $419.00K derived: sum of 3 quarters · filed 2020-08-14 | $542.00K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $139.00K 10-Q · filed 2020-05-14 | $279.00K derived: sum of 2 quarters · filed 2020-05-14 | $402.00K derived: sum of 3 quarters · filed 2020-05-14 | $509.00K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $140.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $263.00K derived: sum of 2 quarters · filed 2020-03-31 | $370.00K derived: sum of 3 quarters · filed 2020-03-31 | $477.00K 10-K/A · filed 2020-03-31 | ||||
| 2018-09-30 | $123.00K 10-Q · filed 2019-11-14 | $230.00K derived: sum of 2 quarters · filed 2019-11-14 | $337.00K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $107.00K 10-Q · filed 2019-08-14 | $214.00K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $107.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $517.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |